Skip to main content
main-content

Type 2 diabetes

Journal articles and book chapters

12-13-2018 | GLP-1 agonists | Review | Article

GLP-1RAs in type 2 diabetes: Mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data

Sposito AC et al. Cardiovasc Diabetol 2018; 17: 157. doi: 10.1186/s12933-018-0800-2

12-07-2018 | Pathogenesis | Review | Article

Melatonin in type 2 diabetes mellitus and obesity

Katamitri A, Jockers R. Nat Rev Endocrinol 2018. doi: 10.1038/s41574-018-0130-1

12-05-2018 | Non-alcoholic fatty liver disease | Article

A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue?

Lonardo A, Lugari S, Ballestri S et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1266-0

11-28-2018 | Diabetic cardiomyopathy | Article

Cardiovascular risk reduction over time in patients with diabetes or pre-diabetes undergoing bariatric surgery: data from a single-center retrospective observational study

Rubio-Almanza M, Cámara-Gómez R, Hervás-Marín D et al. BMC Endocr Disord 2018; 18: 90. doi: 10.1186/s12902-018-0317-4

11-27-2018 | Insulin | Article

Insulin injection technique questionnaire: Results of an international study comparing Brazil, Latin America and World data

Calliari LE et al. Diabetol Metab Syndr 2018; 10: 85. doi: 10.1186/s13098-018-0389-3

11-21-2018 | Cardiovascular disorders | Review | Article

Unrecognised cardiovascular disease in type 2 diabetes: Is it time to act earlier?

Schernthaner G et al. Cardiovasc Diabetol 2018; 17: 145. doi: 10.1186/s12933-018-0788-7

11-15-2018 | Pregnancy | Article

Successful outcomes with insulin degludec in pregnancy: A case series

Hiranput S et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0532-z

11-14-2018 | Charcot foot | Article

Varied presentations and outcomes of Charcot neuroarthropathy in patients with diabetes mellitus

Rastogi A, Prakash M, Bhansali A. Int J Diabetes Dev Ctries 2018. doi: 10.1007/s13410-018-0700-8

11-10-2018 | Retinopathy | Article

Diabetic retinopathy grade as a predictive marker of severity of cardiovascular disease and mortality: DIVERSE Study Group

Shah K et al. Int J Diabetes Dev Ctries 2018. doi: 10.1007/s13410-018-0699-x

11-08-2018 | Cardiovascular disorders | Review | Article

The evolving role of the cardiologist in the management of type 2 diabetes

Chilton RJ et al. Curr Diab Rep 2018; 18: 144. doi: 10.1007/s11892-018-1114-1

11-06-2018 | Diabetes self-management | Article

Exploring how patients understand and assess their diabetes control

Gopalan A et al. BMC Endocr Disord 2018; 18: 79. doi: 10.1186/s12902-018-0309-4

11-06-2018 | Risk factors | Article

Bisphenol A exposure and type 2 diabetes mellitus risk: A meta-analysis

Hwang S et al. BMC Endocr Disord 2018; 18: 81. doi: 10.1186/s12902-018-0310-y

11-03-2018 | Liraglutide (T2DM) | Article

Liraglutide and glycemic outcomes in the LEADER trial

Zinman B et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0524-z

11-03-2018 | Premixed insulins | Review | Article

Expert opinion: Patient selection for premixed insulin formulations in diabetes care

Kalra S et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0521-2

10-31-2018 | Complications | Review | Article

Update on therapeutic options in lipodystrophy

Akinci B, Meral R, Oral EA. Curr Diab Rep 2018; 18: 139. doi: 10.1007/s11892-018-1100-7

10-29-2018 | Type 2 diabetes | Review | Article

Addressing clinical inertia in type 2 diabetes mellitus: A review

Okemah J, Peng J, Quiñones M. Adv Ther 2018. doi: 10.1007/s12325-018-0819-5

image credits